C. Oudejans

发表

Hypersensitivity of bcr-abl-positive progenitors to hyperthermia in patients with chronic myeloid leukemia

G. Schuurhuis, G. Ossenkoppele, J. V. Oostveen, 1997, Leukemia.

Interferon-β bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice

C. Polman, J. Killestein, A. Bertolotto, 2009, Multiple sclerosis.

Chapter 2 . 1 Reduced biological activity of recombinant IFN-β and treatment response IFN-β bioactivity measurement in MS : feasibility for routine clinical practice

H. Vrenken, C. Polman, A. Peña, 2014 .

Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis

H. Vrenken, C. Polman, A. Peña, 2011, Multiple sclerosis.

Relevance of IL 7 R genotype and mRNA expression in Dutch patients with multiple sclerosis

H. Vrenken, C. Polman, A. Peña, 2011 .

Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS

F. Barkhof, C. Polman, D. Knol, 2010, Neurology.

IRF 5 gene variants and pharmacologi al and clinical outcome of IFN-β therapy in MS

X. Montalban, C. Polman, D. Hafler, 2014 .

Lack of interferon‐beta bioactivity is associated with the occurrence of relapses in multiple sclerosis

C. Polman, D. Knol, J. Killestein, 2009, European journal of neurology.

Decreased galanin mRNA levels in growth hormone-releasing hormone neurons after perinatally induced growth retardation.

H. Delemarre-van de Waal, C. Oudejans, C. Huizinga, 2001, The Journal of endocrinology.

Persistent changes in somatostatin and neuropeptide Y mRNA levels but not in growth hormone-releasing hormone mRNA levels in adult rats after intrauterine growth retardation.

H. Delemarre-van de Waal, C. Oudejans, C. Huizinga, 2001, The Journal of endocrinology.